This poster is being hosted on this website in its raw form, without modifications. It has not undergone peer review but has been reviewed to meet AZoNetwork's editorial quality standards. The information contained is for informational purposes only and should not be considered validated by independent peer assessment.
1. CytoBoost™ product range and key benefits
Image Credit: 3D Bio-Tissues
Formulation advantages
- Chemically defined
- 100% serum and xeno-free
- Ready-to-use media additive
- Biocompatible crowders
- Preserves cell quality
- Easily washed/filtered
CytoBoost™ REVIVE
Essential post-thaw rescue additive: Mitigates osmotic shock & anoikis to achieve up to + 50% higher post-thaw recovery and rapid surface attachment.
CytoBoost™ PERFORM
Potent cell expansion and signaling booster: Accelerates proliferation (>70% in multiple cell types, even in serum-free cultures) while enhancing growth factor kinetics.
CytoBoost™ MAXIMISE
Yield and extracellular matrix (ECM) maximizer: Drives ECM deposition and cell growth (>30%) while reducing expensive growth factor media costs by up to 50%.
CytoBoost™ DEVELOP
Precision microenvironment regulator: Controls stem cell fate, preserves pluripotency and lineage state, and enables robust 3D disease model development.
2. Benefits for drug discovery and sustainability
Image Credit: 3D Bio-Tissues
Key advantages for life sciences:
Physiologically relevant assays
- Replicates native volume occupancy (∼50% FVO) for predictive screening
Robust disease models
- Enhances cell fate control (stem cells, spheroids, organoids) in 2D and 3D
Media optimization
- Cuts serum (FBS), albumin, and growth factor media costs by up to 50%
Xeno-free and sustainable
- Fully chemically defined formulation supports animal-free bioprocessing
High process efficiency
- Maximizes product yields (mAbs, EVs) while minimizing batch variation
3. Technology behind CytoBoost: Macromolecular crowding
Image Credit: 3D Bio-Tissues
Fundamental ‘MMC’ mechanism of action
- Recreates dense biology: In vivo interstitial fluids are packed with macromolecules (Ψ ∼50% volume occupancy vs <10% standard in vitro media).
- Excluded volume effect: Excluded space increases effective molecular concentrations and collision frequency without adding excess reagents.
- Thermodynamic driving force: Shifts conformational equilibria toward active, compact protein states and accelerates reaction Vmax.
- Cost and sustainability: Eliminates dependence on serum (FBS) and high factor concentrations while enhancing operational reliability.
4. Application 1: Cell proliferation in serum-free media
Image Credit: 3D Bio-Tissues
Serum-free proliferation and tissue modeling
- Myoblast proliferation: CytoBoost™ PERFORM increased myoblast yield by 77% (p <0.001) in seven-day serum-free cultures.
- Adipocyte yield: CytoBoost™ MAXIMISE increased secondary adipocyte growth by 33% with high lipid vesicle accumulation.
- Preserved cell morphology: High-density growth was achieved without altering cellular phenotype or stemness.
- Microenvironment control: Excluded volume microdomains enhance local signaling thresholds and receptor residency times.
5. Application 2: Post-thaw cell recovery (CytoBoost™ REVIVE)
Image Credit: 3D Bio-Tissues
Key results: 24-hour post-thaw cell rescue
- DF-1 embryonic fibroblasts: Recovery increased from 50 ± 21% (Control) to 88 ± 12% (REVIVE, 10% v/v) (p <0.002).
- Primary CPF4 skin fibroblasts: Recovery improved from 57 ± 15% (Control) to 82 ± 9% (REVIVE) (p <0.01).
- Rescues fragile populations: Overcomes post-thaw apoptotic loss and anoikis without intrinsic cytotoxicity
- Operational consistency: Drastically narrows experimental standard deviation (SD 12% vs 21%), ensuring batch predictability
- Fast surface attachment: Accelerated ECM deposition allows rapid attachment and immediate proliferation post-thaw
6. Application 3: Growth factor and receptor bioactivity
Image Credit: 3D Bio-Tissues
Receptor kinetics and bioactivity enhancement
- Higher maximal response (Vmax): CytoBoost™ PERFORM significantly increases Luciferase signal for TGF-β1 & TGF-β3.
- Increased sensitivity/lower EC50: CytoBoost™ MAXIMISE shifts EC50 for TGF-β1 from 43.6 pg/mL to 22.4 pg/mL.
- Thermal and kinetic stability: Boosts signaling efficiency of thermostable FGF2 (FGF2-G3), porcine FGF-2, and EGF
- Reduced media costs: Higher bioactivity permits up to a 50% reduction in expensive recombinant growth factors
Summary and market impact
CytoBoost™ bridges the gap between traditional dilute cell culture media and dense in vivo biology.
By introducing biocompatible macromolecular crowders, CytoBoost™:
- Solves critical post-thaw recovery bottlenecks (+ 50% cell rescue)
- Boosts cell proliferation and tissue density in serum-free media
- Maximizes growth factor bioactivity and receptor signaling
- Lowers bioprocessing costs while supporting animal-free formulations
Target applications: Bioprocessing, biopharma, drug discovery assays, stem cell therapeutics, and cellular agriculture
About 3D Bio-Tissues
3D Bio-tissues (3DBT) is a biotechnology company redefining the efficiency of cell-based therapies and cellular agriculture. We specialize in the development of macromolecular crowders - simple, powerful media additives designed to mimic the natural physiological environment, accelerating growth and significantly reducing operational costs. At the core of our innovation is a commitment to making complex biology scalable. By optimizing the way cells interact with their environment, we help our partners move from lab-scale success to industrial-scale reality.
About ELRIG (UK) Ltd.
The European Laboratory Research & Innovation Group (ELRIG) is a leading European not-for-profit organization that exists to provide outstanding scientific content to the life science community. The foundation of the organization is based on the use and application of automation, robotics and instrumentation in life science laboratories, but over time, we have evolved to respond to the needs of biopharma by developing scientific programs that focus on cutting-edge research areas that have the potential to revolutionize drug discovery.
Comprised of a global community of over 12,000 life science professionals, participating in our events, whether it be at one of our scientific conferences or one of our networking meetings, will enable any of our community to exchange information, within disciplines and across academic and biopharmaceutical organizations, on an open access basis, as all our events are free-of-charge to attend!
Our values
Our values are to always ensure the highest quality of content and that content will be made readily accessible to all, and that we will always be an inclusive organization, serving a diverse scientific network. In addition, ELRIG will always be a volunteer led organization, run by and for the life sciences community, on a not-for-profit basis.
Our purpose
ELRIG is a company whose purpose is to bring the life science and drug discovery communities together to learn, share, connect, innovate and collaborate, on an open access basis. We achieve this through the provision of world class conferences, networking events, webinars and digital content.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.net, which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.
Last Updated: Oct 12, 2026